プロジェニータ細胞,マイクログリア,および非コーディングRNA: 膠芽細胞の病原性および治療抵抗のオーケストラ
Adil Husain1, Firoz Ahmad2, Sandeep Pandey3
1Department of Biochemistry, Babu Banarasi Das College of Dental Sciences, Babu Banarasi Das University, Lucknow, 226028, Uttar Pradesh, India.
Non-coding RNA research
|September 2, 2025
まとめ
グリオブラストーマ (GB) は攻撃的で,治療に抵抗性がある. プロジェニータ細胞,ミクログリア,およびノンコーディングRNA (ncRNA) は,GBの成長と耐性を駆動し,新しい治療標的を提供する.
科学分野:
- 神経腫瘍学
- 癌 生物学
- 分子生物学
背景:
- グリオブラストーマ (GB) は,その攻撃的な性質と標準的な治療に対する耐性により,重要な治療上の課題を提示しています.
- グリオマ幹細胞 (GSCs) は,原始細胞から発生し,腫瘍の発症,再発,および治療抵抗性の主要な要因です.
- 脳の免疫細胞であるマイクログリアは GBによって操作され 免疫抑制的な環境を育み 腫瘍の進行と治療回避を促進します
研究 の 目的:
- ゲノム細胞,マイクログリア,および非コーディングRNA (ncRNAs) の複合的な役割について見直す.
- これらの成分がグリオブラストーマの治療抵抗にどのように寄与するか解明する.
- グリオブラストーマの治療結果を改善するために,これらの分子プレーヤーを標的とした新しい治療戦略を探求する.
主な方法:
- グリオブラストーマ,プロジェニータ細胞,マイクログリア,非コーディングRNAに焦点を当てた文献レビュー.
- グリオブラストーマの発症,進行,および耐性の基礎となる分子機構の分析.
- グリオブラストームの微小環境における細胞成分とncRNAの相互作用に関する現在の研究の統合.
主要な成果:
- プロジェニータ細胞 (GSCs) は,可塑性を示し,腫瘍の再発と抵抗を誘発する.
- 免疫抑制性腫瘍の微小環境を作り出すために,マイクログリアはグリオブラストーマ細胞によって併用されます.
- 非コーディングRNAs (miRNAs, lncRNAs) は遺伝子発現を調節し,相互作用を調節し,耐性メカニズムに影響を与える.
結論:
- プロジェニター細胞,マイクログリア,NCRNAの複雑な役割を理解することは 膠芽細胞腫の治療に不可欠です.
- これらの相互接続された経路をターゲットにすることで 結晶芽細胞腫の治療抵抗を克服する 約束された戦略が提供されます
- これらの分子因子に関するさらなる研究により,膠芽細胞腫患者の臨床結果が改善される可能性があります.
さらに関連する動画
05:45Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
9.7K
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.7K
関連する概念動画
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:28Biosynthesis of Nucleic Acids
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...